These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4141901)

  • 21. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Inhibition of ristocetin-induced platelet aggregation by haemaccel.
    Stibbe J; Kirby EP
    Br Med J; 1975 Jun; 2(5973):750-1. PubMed ID: 1079739
    [No Abstract]   [Full Text] [Related]  

  • 23. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ristocetin--a new tool in the investigation of platelet aggregation.
    Howard MA; Firkin BG
    Thromb Diath Haemorrh; 1971 Oct; 26(2):362-9. PubMed ID: 5316292
    [No Abstract]   [Full Text] [Related]  

  • 25. [Willebrand's disease and platelet adhesiveness in the presence of ristocetine].
    Alexander P; Streiff F; Stoltz JF; Andre E
    Blut; 1975 Aug; 31(2):87-94. PubMed ID: 1080678
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease.
    Takahashi H
    Thromb Res; 1980 Sep; 19(6):857-67. PubMed ID: 6781099
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Willebrand disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein.
    Takahashi H; Sakuragawa N; Shibata A
    Am J Hematol; 1980; 8(3):299-308. PubMed ID: 6774612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherited variants of factor-VIII-related protein in von Willebrand's disease.
    Peake IR; Bloom AL; Giddings JC
    N Engl J Med; 1974 Jul; 291(3):113-7. PubMed ID: 4546110
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelets and von Willebrand disease.
    Ruggeri ZM; Zimmerman TS
    Semin Hematol; 1985 Jul; 22(3):203-18. PubMed ID: 3929388
    [No Abstract]   [Full Text] [Related]  

  • 34. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aspirin on platelet aggregation and bleeding time in haemophilia and von Willebrand's disease.
    Praga C; Cortellaro M
    Acta Med Scand Suppl; 1971; 525():219-21. PubMed ID: 5317107
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: 8-related antigen and von Willebrand factor.
    Firkin B; Koutts J
    Lancet; 1974 Apr; 1(7861):803-4. PubMed ID: 4132731
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
    Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
    Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Von Willebrand factor and factor-viii-related antigen.
    Stableforth P; Barrowcliffe TW; Dormandy K
    Lancet; 1974 Apr; 1(7859):685. PubMed ID: 4132355
    [No Abstract]   [Full Text] [Related]  

  • 39. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

  • 40. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.